Lucira Health to Announce Fourth Quarter 2021 Financial Results

Rhea-AI Summary

Lucira Health, Inc. (LHDX) will announce its fourth quarter 2021 financial results on March 10, 2022. A conference call and webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and provide corporate updates. Lucira Health specializes in innovative infectious disease test kits, including the Lucira Check-It COVID-19 Test Kit, which provides results in approximately 30 minutes. The company aims to deliver lab-quality testing in a compact, user-friendly format.

Positive

• Announcement of fourth quarter 2021 financial results indicates potential engagement with investors.
• Lucira's rapid COVID-19 testing kits are designed for quick results, enhancing their market offering.

Negative

• None.

News Market Reaction – LHDX

-3.31%

-3.31% Session move

In the trading session that priced this news, LHDX declined 3.31%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report fourth quarter 2021 financial results on, Thursday, March 10, 2022. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details
The conference call can be accessed by dialing (833) 562-0151 for participants in the U.S. or Canada and (661) 567-1232 for international callers, using conference ID 9897752. A live and archived webcast of the event can be accessed through the following link ir.lucirahealth.com.

About Lucira Health, Inc.

Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time. The Lucira™ Check-It COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.

Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
332-895-3230

FAQ

When will Lucira Health report its fourth quarter 2021 financial results?

Lucira Health will report its fourth quarter 2021 financial results on March 10, 2022.

What time is the Lucira Health conference call for financial results?

The conference call will take place at 1:30 p.m. PT / 4:30 p.m. ET.

What products does Lucira Health offer for COVID-19 testing?

Lucira Health offers the Lucira Check-It COVID-19 Test Kit and the Lucira COVID-19 All-In-One Test Kit, both providing results in about 30 minutes.

How can investors access the Lucira Health conference call?

Investors can access the conference call by dialing (833) 562-0151 for U.S. participants or (661) 567-1232 for international callers, using conference ID 9897752.